Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Fed Chair Warsh Says Inflation Risks Have Eased, Reaffirms 2% Target

• Federal Reserve Chair Kevin Warsh said inflation risks have eased in recent weeks while reaffirming commitment to the 2 percent target.

Nitish Kishor | 02 July 2026

US Markets Slip as AI Rally Concerns Weigh Ahead of June Jobs Report

US equity markets ended lower on Wednesday as investors questioned the durability of the AI-led rally. The S&P 500 slipped 0.2%, while the Nasdaq 100 declined 1.5% amid heavy selling in semiconductor stocks. Micron Technology fell 10.6%, AMD dropped 6.9%, and Intel lost 9% …

Team Kalkine | 02 July 2026

SurgePays (NASDAQ:SURG): Why Is This Penny Stock Up 52% Pre-Market Today?

• The stock jumped over 61% in after-hours trading following the announcement.

Nitish Kishor | 02 July 2026

Senmiao Technology (NASDAQ:AIHS): Why Is This Penny Stock Up 7% Pre-Market Today?

• Fiscal 2026 revenue fell 18.5% year over year to $1.546 million.

Nitish Kishor | 02 July 2026

Yiren Digital (NYSE:YRD): Why Is This Penny Stock Up 13% Pre-Market Today?

• The board authorized a new $20 million share repurchase program.

Nitish Kishor | 02 July 2026

LQR House (NASDAQ:YHC): Why Is This Penny Stock Down 21% Pre-Market Today Despite New ByteDance AI Deal?

• Subsidiary YHC AI Limited signed a two-year agreement with ByteDance's BytePlus unit.

Nitish Kishor | 02 July 2026

Robinhood Markets (NASDAQ:HOOD) Gains 3% Pre-Market Today, Extending Rally on Global Expansion Push

• The company unveiled a global expansion strategy at a London event, including plans to launch crypto trading in the UK.

Nitish Kishor | 02 July 2026

Linkhome Holdings (NASDAQ:LHAI): Why Is This Penny Stock Down 32% Pre-Market Today Despite GPU Financing Launch?

• The company completed its acquisition of 100% of Mortgage One Group's equity interests.

Nitish Kishor | 02 July 2026

Roivant Sciences (NASDAQ:ROIV) Edges Up 1% Pre-Market Today Despite Wave of Insider Selling

• A director-linked entity sold over 1.4 million shares worth approximately $49 million.

Nitish Kishor | 02 July 2026

REGENXBIO (NASDAQ:RGNX) Jumps 6% Pre-Market Today as Gene Therapy Trial Milestone Triggers $100 Million AbbVie Payment

• The stock jumped over 9% in the prior session on the trial dosing news.

Nitish Kishor | 02 July 2026
Support

Hi! How can we help you today?

Loading…